Bellerophon Therapeutics | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Mar 6 11:34 ET
Bellerophon Therapeutics | 8-K: Current report
Mar 4 17:55 ET
Bellerophon Therapeutics | DEFA14A: Others
Feb 12 15:50 ET
Bellerophon Therapeutics | DEFA14A: Others
Feb 12 12:40 ET
Bellerophon Therapeutics | 8-K: Current report
Jan 30 09:32 ET
Bellerophon Therapeutics | 8-K: Current report
Jan 22 00:00 ET
Bellerophon Therapeutics | 8-K: Current report
Jan 10 00:00 ET
Bellerophon Therapeutics | DEFA14A: Others
Jan 3 00:00 ET
Bellerophon Therapeutics | 8-K: Current report
Dec 12, 2023 16:10 ET
Bellerophon Therapeutics | 8-K: Current report
Nov 21, 2023 16:05 ET
Bellerophon Therapeutics | DEF 14A: Definitive information statements
Nov 6, 2023 16:30 ET
Bellerophon Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Oct 27, 2023 10:50 ET
Bellerophon Therapeutics | S-8 POS: S-8 POS
Oct 16, 2023 13:59 ET
Bellerophon Therapeutics | S-8 POS: S-8 POS
Oct 16, 2023 13:58 ET
Bellerophon Therapeutics | S-8 POS: S-8 POS
Oct 16, 2023 13:58 ET
Bellerophon Therapeutics | S-8 POS: S-8 POS
Oct 16, 2023 13:57 ET
Bellerophon Therapeutics | S-8 POS: S-8 POS
Oct 16, 2023 13:56 ET
Bellerophon Therapeutics | S-8 POS: S-8 POS
Oct 16, 2023 13:56 ET
Bellerophon Therapeutics | S-8 POS: S-8 POS
Oct 16, 2023 13:55 ET
Bellerophon Therapeutics | S-8 POS: S-8 POS
Oct 16, 2023 13:54 ET
No Data
No Data